Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : 2026 TeoTwawKi ... 2032 Darkest Interregnum -- Ignore unavailable to you. Want to Upgrade?

To: THE ANT who wrote (178144)	9/11/2021 9:30:12 PM
From: arun gera	Read Replies (2) \| Respond to of 219660

Also add Aspirin. Why is everyone so obsessed with Ivermectin? webmd.com The research was led by Eli Magen, from the Barzilai Medical Center in Ashkelon, Israel. His team tracked data on nearly 10,500 people who were tested for COVID-19 during the first wave of the pandemic in Israel, from February to the end of June of last year. Because the study was a look back at prior data, it wasn't designed to show cause-and-effect, only associations. But Magen's group found that people who'd already been taking low-dose aspirin to reduce their risk of heart disease had a 29% lower risk of contracting COVID-19 compared to those who didn't take aspirin, and that rates of aspirin use were much lower among COVID-19 patients than among those who didn't get infected. Among people who did get COVID-19, the time it took for SARS-CoV-2 PCR test results to go from positive to negative was significantly shorter among those who used aspirin, and the duration of their disease was two-three days shorter, depending upon preexisting health conditions. -Arun